Atlas Trials

Prognostic Value of Liver Cancer CTCs Isolated by a Novel Microfluidic Platform

Clinical trial NCT05242237 · UNKNOWN

Trial details

NCT number
NCT05242237
Sponsor
The Second Affiliated Hospital of Chongqing Medical University
Status
UNKNOWN
Study type
OBSERVATIONAL
Hepatocellular CarcinomaCirculating Tumor CellWhole Genome Sequencing
Start date
2021-12-01
Primary completion
2024-01-31
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.